Search Results

Researchers Share Key Career Advice with LLS College Club Members

I recently had the privilege of moderating an LLS on Campus Researcher Panel attended by LLS college club members from nearly 30 universities across the country. These clubs bring together students interested in pursuing health-related careers and provide opportunities to hear from scientists working to better understand and treat blood cancers.  

Surviving ALL: An Intimate Look at How Cancer Affected the Careers, Relationships & Fertility of Four Young Adults

A cancer diagnosis is a devastating blow for people of all ages, but presents special challenges for young adults. This period of life is usually a time of transition as they are embarking on journeys such as school, relationships and careers. A cancer diagnosis can bring their lives to a screeching halt in the midst of these new adventures.

Meet the Researcher: Omar Abdel-Wahab, MD

This is part of a periodic series of Q&A’s with LLS-funded researchers. Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (switch on and off) gene activity. He is studying how these processes drive the development of acute myeloid leukemia and other blood cancers. He currently holds a Career Development Program grant from LLS, a program that supports scientists earlier in their careers.

Q. What is the focus of your research and its primary goal?

Champions in myeloma research: A conversation with Urvi A. Shah, M.D. M.S.

March is Myeloma Awareness Month, and it’s also Women’s History Month. So what better time to spotlight LLS-funded women scientists who are driving discovery for myeloma patients.

In this first of my two-part series on myeloma researchers, I sat down with Urvi A. Shah, MD, MS, an Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center. 

Career Development Program FAQ

Career Development Program (CDP)

Apply to the Career Development Program (CDP)

Creating Great Investigators: LLS’s New Pathway To Medical Science For Underrepresented Minorities

Helping Survivors Lead Longer Better Lives

Late last year I had the privilege of attending a special screening of the documentary American Symphony. The film chronicles the experiences of writer Suleika Jaouad and her husband musician Jon Batiste after learning that her acute myeloid leukemia (AML) had returned after years of remission. The movie shows how the couple navigates uncertainty, treatment, and their new normal afterwards. 

Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.

To commemorate both Myeloma Awareness Month and Women’s History Month during March, I’ve been talking with LLS-funded women scientists who are driving discovery for myeloma patients. As we close out the month and my two-part series on myeloma researchers, I’m excited to share my recent conversation with Suzanne Lentzsch, M.D., Ph.D., Professor of Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University. 

Meet The Researcher: Dr. Christopher R. Flowers

Meet The Researcher: Dr. Rayne Rouce

First Day Message from LLS's New President and CEO

Honoring Blood Cancer Survivors

Throughout June, in commemoration of #NationalCancerSurvivorMonth, we at LLS have been highlighting the resilience and achievements of blood cancer survivors. I’ve treated so many incredible young survivors in my years as a pediatric hematologist oncologist, and all of them hold a special place in my heart. 

Nutrition Advice from a Dietitian & Blood Cancer Survivor

76-year-old Barbara Borrell is a woman who wears many hats – a 50+ year registered dietitian, nutrition consultant and educator, cancer advocate, volunteer with The Leukemia & Lymphoma Society, and a blood cancer survivor who has battled not one, not two, but three types of blood cancer.

Bold goal, bold action

As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer, the children with blood cancer I have had the honor of knowing, and the many individuals and families who have been impacted by a blood cancer diagnosis.

Our work at The Leukemia & Lymphoma Society (LLS) has had a positive impact on so many, but we can do even more to accelerate progress for the blood cancer patients we serve.

Beyond the diagnosis: How employers can champion employees facing cancer

“When someone faces cancer, they shouldn't have to go it alone.” – Orlando Ashworth, CPO, LLS

Cancer doesn’t just impact an individual. It sends ripples through families, friendships, and workplaces. 

Work, School & Finances

Some people continue to work or attend school through cancer treatment, but others are not able to do so. Talk to your healthcare team to know what to expect from treatment so you can make the decision that is best for you.

Bishoy

Born in Egypt, at the age of three, me and my family immigrated to the U.S. when I was diagnosed with acute lymphoblastic leukemia (ALL). I grew up in Long Island, New York, where I received treatment for 10 years. On my 13th birthday, I underwent brain surgery and remains cancer-free.

Glenn

I was diagnosed with CLL in 2010 after feeling tired all the time, bruising easily, significant joint pain, a hot mess. I was told I could be treated but never cured. I survived an earlier cancer via radiation therapy where I was over radiated. I had never been so sick in all my life. While I don't ignore my condition I've decided to live best I can. I have a loving family and friends and a good career. I stay active as a volunteer firefighter (my way of giving back in honor of 911 victims as I was on the NYFD career list in 1999), home improvements, and attending family functions.

Ryan

I am a 12 year survivor of acute lymphoblastic leukemia (ALL) and was heavily involved with LLS when I was a patient going through treatment. I was a part of the Honored Hero program during elementary and middle school and would go speak and tell my story to schools in the Cincinnati Tri-State area with my mother.

Matthew

In 2014, I was diagnosed with Burkitt’s lymphoma, one of the most aggressive of all blood cancers and without quick action I would have had only 90 days to live. That was three years ago.

How Patients Really Feel About Artificial Intelligence in Healthcare

It seems that everywhere we turn lately we hear something about the promises and the perils of artificial intelligence (AI). AI is touted as a smart, efficient tool that can speed and streamline processes, analyze and manage complex data, and cut time and costs.

In the healthcare setting, it has the potential to be used to review and gather medical information quickly, screen for risk of disease and suggest diagnoses, provide second opinions, prevent harmful medication interactions, identify treatment options and clinical trials, reduce patient wait times, and much more.

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma